Stocks · Korea
256940
KOSDAQ
Keeps Biopharma
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+21.55%
1M+35.35%
3M+20.95%
6M-7.63%
1Y-34.54%
YTD-35.91%
52W high12,880원
52W low5,110원
From 52W high-42.62%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 146억 | -86억 | -120억 | -58.9% |
| 2023 | 921억 | 31억 | 35억 | 3.3% |
| 2024 | 1,276억 | 62억 | 16억 | 4.9% |
| 2025 | 1,701억 | 16억 | -104억 | 0.9% |
| Quarterly | ||||
| 2024 4Q | 328억 | -13억 | 14억 | -4.0% |
| 2025 1Q | 406억 | 89,335,689원 | -14억 | 0.2% |
| 2025 2Q | 433억 | -10억 | 7억 | -2.2% |
| 2025 3Q | 409억 | 14억 | -4억 | 3.5% |
| 2025 4Q | 452억 | 10억 | -92억 | 2.2% |
| 2026 1Q | 594억 | -7억 | 57억 | -1.1% |
Company
Address: 서울특별시 강남구 테헤란로13길 8-11 킵스빌딩 4층
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-07-06[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.